|
|||||
|
|
Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes |
|
| Authors: | Heinzerling Keith G Kral Alex H Flynn Neil M Anderson Rachel L Scott Andrea Gilbert Mary L Asch Steven M Bluthenthal Ricky N |
| Affiliation: | aDepartment of Family Medicine and Integrated Substance Abuse Programs, University of California-Los Angeles, Los Angeles, CA, USA bVA Greater Los Angeles Health Care System, Los Angeles, CA, USA cRTI International, San Francisco, CA, USA dDepartment of Family and Community Medicine, University of California-San Francisco, San Francisco, CA, USA eDivision of Infectious Diseases, Department of Internal Medicine, University of California-Davis, Sacramento, CA, USA fHealth Program and Drug Policy Research Center, RAND, Santa Monica, CA, USA gUrban Community Research Center, California State University, Dominguez Hills, CA, USA |
| Abstract: | We described the availability and outcomes of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) testing services at syringe exchange programs throughout California, using interviews with 24 syringe exchange program directors and 560 syringe exchange clients. Both HIV and HCV testing services were available in 62% of programs, 21% had HIV testing only, and 17% had neither. Programs administered by health care/social service providers were more likely than independent syringe exchange programs to have HIV and HCV testing services available. Among clients of programs with testing available, clients of illegal programs were significantly less likely than clients of legal programs to have used syringe exchange HIV and HCV testing services. The availability of HIV and HCV testing services at syringe exchange programs varies, and the use of existing testing services by clients is not universal. Efforts to increase both the availability of HIV and HCV testing services at syringe exchange programs and the use of existing testing services are needed. |
| Keywords: | HIV testing Hepatitis C virus Syringe exchange programs Injection drug use |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |